Trials / Completed
CompletedNCT02521545
Single-Dose Study of a New Formulation of BIIB061
A Single-Dose Study in Healthy Volunteers to Assess the Pharmacokinetic Profile of a New Formulation of BIIB061
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of the study is to assess the pharmacokinetic (PK) profile of BIIB061 in the new oral formulation in the fasted state in healthy male and female volunteers. The secondary objective of this study is to evaluate the safety and tolerability of BIIB061 in the new formulation in this study population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BIIB061 | Capsule |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2015-08-13
- Last updated
- 2015-09-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02521545. Inclusion in this directory is not an endorsement.